Investing Profile

Robert Garland

VCInvestor
Venture Partner at New Enterprise Associates (NEA)
nea.comSan Francisco, California
Photo of Robert Garland, Venture Partner at New Enterprise Associates (NEA)
Your Intro Paths to Robert Garland

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Robert Garland on

cb
Current Investing Position
New Enterprise Associates (NEA) Venture Partner
Investment Range
$2.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
10
Current Fund Size
$6.2B

Robert Garland is on these Sector & Stage Rankings

Robert Garland's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Cleave Therapeutics
Series BAug 2016$37M
Series AApr 2013$10M
$100M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Peter Thompson (OrbiMed), Kush Parmar (5am Ventures), Andrew Schwab (5am Ventures), Marc Singer (Osage University Partners), Alfred Scheidegger (Nextech Invest), Larry Lasky (The Column Group)
Sagimet Biosciences
Series DDec 2014$29M
Series CJun 2013$20M
Series UnknownOct 2012$8M
Series UnknownJan 2012$20M
Series BJul 2009$30M
$190M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA)), David Mott (Mott Family Capital), Beth Seidenberg (Westlake Village BioPartners)
Trevena
Series BJul 2010$35M
Series AMar 2008$24M
$70M
Co-investors: Terry McGuire (Polaris Partners), Martin Alexander Gershon (Endeavor Venture Funds), Farah Champsi (InterWest)
Cardioxyl Pharmaceuticals
Series ADec 2006$15M
$58M
Co-investors: Peter Thompson (OrbiMed), Bill Harrington (Osage University Partners), James Barrett